GenMark Diagnostics upgraded

Cowen upgraded GenMark Diagnostics (Nasdaq: GNMK) from a Market Perform rating to an Outperform rating and lifted its price target from $10 to $17 sending the stock price soaring $1.79 to close at $10.61.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.